Skip to main content

Table 6 Adjusted multilevel logistic regression models of health centre and client level factors associated with top quartile delivery of guideline-scheduled generalist physical checks (N = 15,622 clients, 162 health centres)

From: Improvement in delivery of type 2 diabetes services differs by mode of care: a retrospective longitudinal analysis in the Aboriginal and Torres Strait Islander Primary Health Care setting

 

Model A empty

Model B adjusted

Model C adjusted

 

Fixed effects

OR (95 % CI)

ORs (95 % CI)

ORs (95 % CI)

Audit Year

2005/2006

1.00 (reference)

1.00 (reference)

1.00 (reference)

2007

2.45 (1.98–3.03)**

1.75 (1.39–2.20)**

1.82 (1.45–2.29)**

2008

3.20 (2.61–3.93)**

1.97 (1.54–2.50)**

2.10 (1.64–2.68)**

2009

5.09 (4.15–6.25)**

2.96 (2.30–3.80)**

3.05 (2.37–3.92)**

2010

5.11 (4.10–6.36)**

2.87 (2.18–3.76)**

2.89 (2.20–3.79)**

2011

5.12 (4.19–6.26)**

2.99 (2.28–3.92)**

2.99 (2.28–3.93)**

2012

6.56 (5.37–8.04)**

2.86 (2.09–3.90)**

2.86 (2.10–3.91)**

2013

9.77 (7.92–12.03)**

3.86 (2.78–5.36)**

3.81 (2.74–5.29)**

2014

9.57 (7.41–12.34)**

3.86 (2.67–5.59)**

3.79 (2.62–5.48)**

Health Centre Characteristics

Location X duration of CQI participation

 Non-remote

Baseline

 

1.00 (reference)

1.00 (reference)

1–2 cycles

 

1.77 (1.40–2.24)**

1.71 (1.35–2.17)**

≥3 cycles

 

2.13 (1.49–3.03)**

2.02 (1.42–2.89)**

 Remote

Baseline

 

1.00 (reference)

1.00 (reference)

1–2 cycles

 

1.36 (0.90–2.05)

1.35 (0.90–2.04)

≥3 cycles

 

1.35 (0.84–2.15)

1.35 (0.85–2.16)

 Governance

Community-Controlled

 

1.00 (reference)

1.00 (reference)

Government operated

 

0.73 (0.48–1.11)

0.74 (0.49–1.13)

 Service population

≤500

 

1.00 (reference)

1.00 (reference)

501–999

 

1.01 (0.67–1.52)

1.01 (0.67–1.51)

≥1000

 

0.72 (0.49–1.05)

0.71 (0.49–1.04)

 % Clients attending in past 6 months

<97 %

 

1.00 (reference)

1.00 (reference)

≥97 %

 

1.39 (1.25–1.55)**

1.38 (1.23–1.54)**

Client Characteristics

 Sex

Male

  

1.00 (reference)

Female

  

1.02 (0.95–1.10)

 Age

≥15- < 25

  

1.00 (reference)

≥25- < 40

  

1.09 (0.81–1.47)

≥40- < 55

  

1.43(1.06–1.92)*

≥55

  

1.52 (1.13–2.05)**

 Indigenous Status

Non-Indigenous

  

1.00 (reference)

Indigenous

  

1.27 (1.06–1.51)**

 Comorbidity

None

  

1.00 (reference)

One or more

  

1.31 (1.19–1.44)**

 Complications

No complications

  

1.00 (reference)

1–2 complications

  

1.16 (1.03–1.30)*

>2 complications

  

0.90 (0.74–1.09)

Random effects (intercepts)

 

State (variance (SE))

0.80 (0.55)

0.39 (0.28)

0.39 (0.28)

MORSTATE

2.34

1.82

1.82

 PCV (% explained variance)

-

51 %

51 %

 Health Centre (variance (SE))

0.90 (0.12)

0.79 (0.11)

0.78 (0.11)

 

MORHC

2.47

2.34

2.32

 PCV (% explained variance)

-

12 %

14 %

 State & Health Centre (variance)

1.70

1.19

1.17

 

MORSTATE-HC

3.47

2.83

2.81

 PCV (% explained variance)

-

30 %

31 %

 

Patient (variance (SE))

0.11 (0.05)

0.14 (0.05)

0.07 (0.03)

  1. MOR (Median odds ratio): odds of receiving ‘top quartile’ service delivery if patient was to change health centre or jurisdiction; PCV (Proportional change in variance): percent variation explained in odds for better health care delivery by introduction of health centre or patient level factors
  2. *p < 0.05
  3. **p = <0.01
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us